Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print UT Southwestern patient first in North Texas to receive newest-generation heart failure device

UT Southwestern patient first in North Texas to receive newest-generation heart failure device

October 27, 2009

UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant.

Called a left-ventricular assist device (LVAD), its purpose is to help a patient's weakened heart pump blood throughout the body. For Mr. LeBlanc, it will help his ailing heart continue to pump until the Irving resident receives a new heart. UT Southwestern is the only medical facility in North Texas implanting the HeartWare Ventricular Assist System as part of a national clinical trial testing the effectiveness of the device.




The HeartWare Ventricular Assist System is a little smaller than a hockey puck and two and half times smaller than the earliest versions of LVADs.

Mr. LeBlanc, a Chicago native, moved to the Dallas area 11 years ago in search of new job opportunities. The normal trajectory of his daily life veered wildly when a simple episode of fainting resulted in a life-changing diagnosis: heart failure.

"I kept getting weaker and weaker," he said. "I was blacking out for no reason. I hadn't been sick and have never been a sickly person."

Occasionally, viruses can attack the heart and leave it severely damaged, but people may not know until months or years later. Mr. LeBlanc's doctors theorized he may have had such a virus that ultimately led to heart failure.

"My energy level was up and down. To keep me going, I qualified for a defibrillator, which basically shocked me if my heart rhythm started to get worse," Mr. LeBlanc said. "But as I got sicker, the defibrillator kept going off, and it was awful."

Even with the defibrillator, Mr. LeBlanc suffered a heart attack in April, followed by a stroke in July. Luckily, he was able to get to an emergency room before the stroke did too much damage. After several more weeks in and out of hospitals, Mr. LeBlanc was referred to UT Southwestern University Hospital - St. Paul, where he met with cardiologists and cardiothoracic surgeons who determined he would be a good candidate for the new LVAD.

"Mr. LeBlanc has cardiomyopathy, which causes the heart to dilate. The muscle becomes weaker, and it can't pump efficiently," said Dr. Dan Meyer, professor of cardiovascular and thoracic surgery at UT Southwestern and Mr. LeBlanc's surgeon. "UT Southwestern has always had a presence in studying new mechanical assist devices, so we were honored to be only one of two sites in the state selected to implant the HeartWare LVAD as part of a national clinical trial."

The pump is designed to rest inside the patient's chest. A small cable attached to the device exits the body and connects to an externally worn controller. The controller is powered by a battery pack. The HeartWare LVAD has only one moving part, which contributes to its diminutive size. The lack of mechanical bearings is expected to lead both to longer-term device reliability and to a reduced risk of physical damage to blood cells as they pass through the pump, said Dr. Meyer, also director of the mechanical support program at UT Southwestern.

"The size of the device means the incision is also smaller. The entire implantation surgery takes about four hours," Dr. Meyer said. "Mr. LeBlanc is a really great patient. He's otherwise very healthy, and we believe he will do very well with the LVAD until he can get a new heart."

Only a few days after his surgery to implant the device, Mr. LeBlanc said he was feeling much better and he hopes for a quick return to his daily routine. He's still adjusting to some of the stranger side effects of his new device, including no pulse. The LVAD keeps blood moving continually with no pulsation, so he no longer has a palpable heart beat or traditionally measurable blood pressure.

"I'm very happy to have this LVAD, and I think I'll adjust to it fast. I'm just ready to get on with my life," Mr. LeBlanc said. "I've been through everything, and I hope this is the last step I need to take before transplant surgery."

UT Southwestern Medical Center




More Heart Failure Device Current Events and Heart Failure Device News Articles
Heart Failure: Device Management

Heart Failure: Device Management
by Arthur Feldman (Editor)

When you're considering device therapy for a patient with heart failure, be sure to consult this concise reference for the latest information on who benefits most from which device.In clear, straightforward prose, Dr. Feldman addresses: Resynchronization Therapy, ICD, Ultrafiltration, Impulse Therapy, Chronic Implantable Monitoring, Bioimpedance, EECP, and more. With chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.

HeartMate XVE LVAS - Patient Education Program (Advanced Heart Failure System)

HeartMate XVE LVAS - Patient Education Program (Advanced Heart Failure System)

Advanced heart failure patients deserve to receive a realistic, informative appraisal of their condition, tempered with a message of hope. While every healthcare provider has a unique way of communicating with patients, you can use the information in this video as a starting point to inform discussions about HeartMate XVE LVAS, advanced-stage heart failure therapy. The Thoratec HeartMate® XVE LVAS (vented electric) was developed and tested by Thermo Cardiosystems, Inc. and the Texas Heart Institute. This patient is able to leave the hospital while being supported by this device, paving the way for other patients to routinely wait at home for their transplants. Because the system is relatively easy to use, patients and their families can maintain it outside the hospital setting. Patients...

  Home monitoring helps to manage heart failure: automated devices, when added to standard disease management, improved short-term clinical outcomes.(Cardiovascular ... An article from: Internal Medicine News
by Damian McNamara (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on March 1, 2006. The length of the article is 623 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Home monitoring helps to manage heart failure: automated devices, when added to standard disease management, improved short-term clinical outcomes.(Cardiovascular Medicine)
Author: Damian McNamara
Publication: Internal Medicine News (Magazine/Journal)
Date: March 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 5 Page: 45(1)

Distributed by Thomson...

Device Therapy in Heart Failure (Contemporary Cardiology)

Device Therapy in Heart Failure (Contemporary Cardiology)
by William H. Maisel (Editor)

Heart failure affects over 5 million patients in the United States alone, and is a chronic and debilitating disease. While a number of pharmacologic therapies have shown varying degrees of effectiveness, many recent advances in the treatment of heart failure has focused on device based therapies. In Device Therapy in Heart Failure, William H. Maisel and a panel of authorities on the use and implementation of device based therapies provide a comprehensive overview of the current and developing technologies that are used to treat heart failure. Individual chapters provide an in-depth analysis of devices such as CRT’s and ICD’s, while broader topics such as the pathophysiology of heart failure and its current medical therapies are also discussed. Additional topics include Pacing and...

  Panel Backs Device for Advanced Heart Failure.: An article from: Internal Medicine News
by Elizabeth Mechcatie (Author)

This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2001. The length of the article is 982 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Panel Backs Device for Advanced Heart Failure.
Author: Elizabeth Mechcatie
Publication: Internal Medicine News (Magazine/Journal)
Date: August 15, 2001
Publisher: International Medical News Group
Volume: 34 Issue: 16 Page: 15

Distributed by Thomson...

Device Therapy for Congestive Heart Failure

Device Therapy for Congestive Heart Failure
by Kenneth A. Ellenbogen (Author), Bruce L. Wilkoff (Author), G. Neal Kay (Author)

The field's foremost authorities offer guidance on the use of implantable cardioverter defibrillators (ICDs) and pacemakers for the management of congestive heart failure. They explain how these devices work; examine the patient-and device-selection proce * Discusses patient selection as well as aftercare. * Features practice guidelines and techniques for implanting all new devices. * Offers an outstanding review of cardiovascular anatomy. * Provides an overview on the prognosis for congestive heart failure, and clinical rationales for the selection of device therapy. * Reviews the results of clinical trials.

  Drugs, devices differ for two heart failure types.(Disease/Disorder overview): An article from: Internal Medicine News
by Alicia Ault (Author)

This digital document is an article from Internal Medicine News, published by Thomson Gale on May 1, 2006. The length of the article is 640 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Drugs, devices differ for two heart failure types.(Disease/Disorder overview)
Author: Alicia Ault
Publication: Internal Medicine News (Magazine/Journal)
Date: May 1, 2006
Publisher: Thomson Gale
Volume: 39 Issue: 9 Page: 48(1)

Article Type: Disease/Disorder overview

Distributed by Thomson...

  MEDTRONIC DEVICE THERAPIES RECOMMENDED FOR HEART FAILURE.: An article from: Biotech Equipment Update
by Thomson Gale (Publisher)

This digital document is an article from Biotech Equipment Update, published by Thomson Gale on October 1, 2005. The length of the article is 798 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: MEDTRONIC DEVICE THERAPIES RECOMMENDED FOR HEART FAILURE.
Publication: Biotech Equipment Update (Newsletter)
Date: October 1, 2005
Publisher: Thomson Gale
Volume: 13 Issue: 10 Page: NA

Distributed by Thomson Gale

  New devices offer hope for heart failure patients: next generation pumps offer a boost for failing hearts, while researchers explore ways to live better ... risk.: An article from: Men's Health Advisor
by Unavailable (Author)

This digital document is an article from Men's Health Advisor, published by Belvoir Media Group, LLC on August 1, 2008. The length of the article is 987 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: New devices offer hope for heart failure patients: next generation pumps offer a boost for failing hearts, while researchers explore ways to live better with the disease and reduce your risk.
Author: Unavailable
Publication: Men's Health Advisor (Magazine/Journal)
Date: August 1, 2008
Publisher: Belvoir Media Group, LLC
Volume: 10 Issue: 8 Page: 1(2)

Distributed by Gale, a part of Cengage...

  Ventricular assist devices give failing hearts a boost: tiny pumps enable patients with severe heart failure to live longer, better lives.(BREAKTHROUGHS): An article from: Heart Advisor
by Unavailable (Author)

This digital document is an article from Heart Advisor, published by Belvoir Media Group, LLC on May 1, 2009. The length of the article is 690 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser.

Citation Details
Title: Ventricular assist devices give failing hearts a boost: tiny pumps enable patients with severe heart failure to live longer, better lives.(BREAKTHROUGHS)
Author: Unavailable
Publication: Heart Advisor (Magazine/Journal)
Date: May 1, 2009
Publisher: Belvoir Media Group, LLC
Volume: 12 Issue: 5 Page: 5(1)

Distributed by Gale, a part of Cengage...

© 2009 BrightSurf.com